Based on the clinical manifestation and history, subjects were classified to the following three non-IgE CMPA phenotypes: (a) 11 subjects (77.33%) with FPIAP, (b) 3 (20%) with FPIES, and (c) 1 (6.7%) with severe diarrhoea due to enteropathy. This evidence concerns the gene IGHE and Abnormal intestine morphology.